eLaws | eCases | United States Code | Federal Courts |

Cystic Fibrosis Foundation - Comment

Document ID: FDA-2013-N-0196-0014
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: May 07 2013, at 12:00 AM Eastern Daylight Time
Date Posted: May 21 2013, at 12:00 AM Eastern Standard Time
Comment Start Date: March 8 2013, at 12:00 AM Eastern Standard Time
Comment Due Date: May 7 2013, at 11:59 PM Eastern Standard Time
Tracking Number: 1jx-857a-jn90
View Document:

This is comment on Notice

Prescription Drug User Fee Act V Benefit-Risk Plan

View Comment

Please see attached comments.

Attachments:

Cystic Fibrosis Foundation CFF Risk Benefit Assessment Comments, May 2013

Title:
Cystic Fibrosis Foundation CFF Risk Benefit Assessment Comments, May 2013

View Attachment:

View as format pdf

Related Comments

View All

Total: 14

Cystic Fibrosis Foundation - Comment
Public Submission Posted: 05/21/2013 ID: FDA-2013-N-0196-0014

Comment Period Closed
May 07,2013 11:59 PM ET

Pharmaceutical Research and Manufacturers of America (PhRMA) - Comment
Public Submission Posted: 05/21/2013 ID: FDA-2013-N-0196-0009

Comment Period Closed
May 07,2013 11:59 PM ET

Biotechnology Industry Organization (BIO) - Comment
Public Submission Posted: 05/21/2013 ID: FDA-2013-N-0196-0010

Comment Period Closed
May 07,2013 11:59 PM ET

National Brain Tumor Society - Comment
Public Submission Posted: 05/13/2013 ID: FDA-2013-N-0196-0005

Comment Period Closed
May 07,2013 11:59 PM ET

Centre for Innovation in Regulatory Science - Comment
Public Submission Posted: 05/13/2013 ID: FDA-2013-N-0196-0004

Comment Period Closed
May 07,2013 11:59 PM ET